3/12
10:26 am
sava
Global Pain Therapeutics Market and Modality Trends Report 2026: Currently 391 Innovator Drugs for Pain Indications with Nociceptive Pain Market Expected to See the Highest Growth Rate to 2031 [Yahoo! Finance]
Neutral
Report
Global Pain Therapeutics Market and Modality Trends Report 2026: Currently 391 Innovator Drugs for Pain Indications with Nociceptive Pain Market Expected to See the Highest Growth Rate to 2031 [Yahoo! Finance]
3/12
08:38 am
sava
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Neutral
Report
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/8
01:31 am
sava
Medium
Report
2/19
09:18 am
sava
Cassava Sciences says US DOJ has closed investigation into company [Yahoo! Finance]
Low
Report
Cassava Sciences says US DOJ has closed investigation into company [Yahoo! Finance]
2/19
08:00 am
sava
Cassava Announces Closure of U.S. Department of Justice Investigation
Medium
Report
Cassava Announces Closure of U.S. Department of Justice Investigation
2/1
01:30 am
sava
Cassava Sciences (NASDAQ:SAVA) was upgraded by analysts at
Wall Street Z
Low
Report
Cassava Sciences (NASDAQ:SAVA) was upgraded by analysts at
Wall Street Z
1/24
03:01 am
sava
Cassava Sciences (NASDAQ:SAVA) was downgraded by analysts at
Wall Street
Medium
Report
Cassava Sciences (NASDAQ:SAVA) was downgraded by analysts at
Wall Street
1/13
08:00 am
sava
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
Medium
Report
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
12/27
04:15 pm
sava
Cassava Sciences (NASDAQ:SAVA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Cassava Sciences (NASDAQ:SAVA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.